The training set, which spanned a wide range of pre-meal conditions and patient characteristics, was created in silico by the UVa/Padova T1D Simulator [38], a simulation tool that includes a model of glucose-insulin-glucagon dynamics in subjects with T1D, accepted by the FDA to substitute preclinical trials of certain insulin treatments. This evidence concerns the gene INS and type 1 diabetes mellitus.